Discovery of 3H-imidazo[4, 5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability. Issue 4 (15th February 2015)
- Record Type:
- Journal Article
- Title:
- Discovery of 3H-imidazo[4, 5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability. Issue 4 (15th February 2015)
- Main Title:
- Discovery of 3H-imidazo[4, 5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability
- Authors:
- Ikuma, Yohei
Hochigai, Hitoshi
Kimura, Hidenori
Nunami, Noriko
Kobayashi, Tomonori
Uchiyama, Katsuya
Umezome, Takashi
Sakurai, Yasumitsu
Sawada, Naoyuki
Tadano, Jun
Sugaru, Eiji
Ono, Michiko
Hirose, Yuko
Nakahira, Hiroyuki - Abstract:
- Graphical abstract: Abstract: We have previously reported a novel series of 3 H -imidazo[4, 5- c ]quinolin-4(5 H )-ones with potent dipeptidyl peptidase IV (DPP-4) inhibitory activity. However, these compounds showed poor oral absorption. We attempted in this study esterification of the carboxylic acid moiety to improve the compounds 1 –4 plasma concentrations. Our efforts yielded 10h with a 5-methyl-2-oxo-1, 3-dioxol-4-yl methyl ester as an S9/plasma-cleavable functionality. Compound 10h showed significantly high oral absorption and potent DPP-4 inhibition in vivo and decreased Zucker fatty rats glucose levels in the oral glucose tolerance test. Optimization of the ester moiety revealed that rapid conversion to the carboxyl form in both liver S9 fractions and serum was important for prodrugs not to be detected in the plasma after oral administration. In particular, lability in the serum was found to be an important characteristic. Through our investigation, we were able to develop a novel efficient synthetic method for construction of 3 H -imidazo[4, 5- c ]quinolin-4(5 H )-ones using intramolecular radical cyclization.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 23:Issue 4(2015)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 23:Issue 4(2015)
- Issue Display:
- Volume 23, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 23
- Issue:
- 4
- Issue Sort Value:
- 2015-0023-0004-0000
- Page Start:
- 779
- Page End:
- 790
- Publication Date:
- 2015-02-15
- Subjects:
- Dipeptidyl peptidase IV -- Type 2 diabetes mellitus -- 3H-Imidazo[4, 5-c]quinolin-4(5H)-ones -- Prodrug
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2014.12.051 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14487.xml